The effects of S- and R-flurbiprofen on the inflammation-evoked intraspinal release of immunoreactive substance P - A study with antibody microprobes

Brain Research

Volumn 798, Issue 1-2, 1998, Pages 287-293

  Schaible, Hans Georg ^a   Neugebauer, Volker ^b   Geisslinger, Gerd ^c   Beck, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Immunoreactive substance P; Inflammation; Intraspinal release; Non steroidal anti inflammatory drug; R flurbiprofen; S flurbiprofen

Indexed keywords

FLURBIPROFEN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; IMMUNOREACTIVITY; INFLAMMATION; MICROANALYSIS; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SENSITIZATION; SYNAPTIC TRANSMISSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; FLURBIPROFEN; IMMUNOLOGIC TECHNIQUES; KNEE JOINT; MALE; RATS; RATS, WISTAR; SPINAL CORD; STEREOISOMERISM; SUBSTANCE P;

EID: 0032490602     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00429-6     Document Type: Article

References (46)

1. 2 from innervated rodent tissue, in vitro. Pflüg. Arch. 431:1996;R75.
2. S. Brehm, C. Weidner, B. Averbeck, P.W. Reeh, Block of prostaglandin synthesis reduces chemically induced nociceptor excitation but not substance P release in rabbit pleura; in vitro, IASP Press, Seattle, 1996, 118.
3. Brodin E., Linderoth B., Gazelius B., Ungerstedt U. In vivo release of substance P in cat dorsal horn studied with microdialysis. Neurosci. Lett. 76:1987;357-362.
4. Brune K., Beck W.S., Geisslinger G., Menzel-Soglowek S., Peskar B.M., Peskar B.A. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia. 47:1991;257-261.
5. Brune K., Geisslinger G., Menzel-Soglowek S. Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. J. Clin. Pharmacol. 32:1992;944-952.
6. Carlsson K.-H., Monzel W., Jurna I. Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain. 32:1988;313-326.
7. Duggan A.W., Hendry I.A., Green J.L., Morton C.R., Hutchison W.D. The preparation and use of antibody microprobes. J. Neurosci. Meth. 23:1988;241-247.
8. Duggan A.W., Hendry I.A., Green J.L., Morton C.R., Zhao Z.Q. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res. 451:1988;261-273.
9. Duggan A.W., Schaible H.-G., Hope P.J., Lang C.W. Effect of peptidase inhibition on the pattern of intraspinally released immunoreactive substance P detected with antibody microprobes. Brain Res. 579:1992;261-269.
10. Duggan A.W., Riley R.C., Mark M.A., MacMillan S.J.A., Schaible H.-G. Afferent volley patterns and the spinal release of immunoreactive substance P in the dorsal horn of the anesthetized spinal cat. Neuroscience. 65:1995;849-858.
11. Ferreira S.H. Prostaglandins, aspirin-like drugs and analgesia. Nature. 240:1972;200-203.
12. 2 causes sensitization of the primary afferent neuron via the spinal release of glutamate. Inflamm. Res. 45:1996;499-502.
13. Geisslinger G., Schaible H.-G. New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers. J. Clin. Pharmacol. 36:1996;513-520.
14. Geisslinger G., Ferreira S.H., Menzel S., Schlott D., Brune K. Antinociceptive actions of R(-)-flurbiprofen- a non-cyclooxygenase inhibiting 2-arylpropionic acid - in rats. Life Sci. 54:1994;PL173-177.
15. Gelgor L., Cartmell S., Mitchell D. Intracerebroventricular microinjections of non-steroidal anti-inflammatory drugs abolish reperfusion hyperalgesia in the rat's tail. Pain. 50:1992;323-329.
16. Go V.L.W., Yaksh T.L. Release of substance P from the cat spinal cord. J. Physiol. 391:1987;141-167.
17. Guilbaud G., Iggo A. The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyinflammation. Exp. Brain Res. 61:1985;164-168.
18. Heppelmann B., Pfeffer A., Schaible H.-G., Schmidt R.F. Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain. 26:1986;337-351.
19. Henry J.L. Effects of substance P on functionally identified units in cat spinal cord. Brain Res. 114:1976;439-451.
20. Hintgen C.M., Vasko M.R. Prostacyclin enhances the evoked release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res. 655:1994;51-60.
21. Jurna I., Brune K. Central effects of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen and diclofenac, determined in C-fibre-evoked activity in single neurones of the rat thalamus. Pain. 41:1992;71-80.
22. Jurna I., Spohrer B., Bock R. Intrathecal injection of acetylsalicylic acid, salicylic acid, and indomethacin depresses C fibre-evoked activity in the rat thalamus and spinal cord. Pain. 49:1992;249-256.
23. Kuraishi Y., Hirota N., Sato Y., Hanshima N., Tagaki H., Satoh M. Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ. Neuroscience. 30:1989;241-250.
24. LeGreves P., Nyberg F., Terenius L., Hökfelt T. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur. J. Pharmacol. 115:1985;309-311.
25. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1279.
26. Malmberg A.B., Yaksh T.L. Antinociception produced by spinal delivery of the S- and R-enantiomers of flurbiprofen in the formalin test. Eur. J. Pharmacol. 256:1994;205-209.
27. Mantyh P.W., DeMaster E., Malhotra A., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E., Simone D.A. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science. 268:1995;1629-1632.
28. Mantyh P.W., Rogers S.D., Honore P., Allen B.J., Ghilardy J.R., Li J., Daughters R.S., Lappi D.A., Wiley R.G., Simone D.A. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science. 278:1997;275-279.
29. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain. 59:1994;9-43.
30. McCormack K., Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs. 41:1991;533-547.
31. McMahon S.B., Lewin G.R., Wall P.D. Central hyperexcitability triggered by noxious inputs. Curr. Opin. Neurobiol. 3:1993;602-610.
32. Neugebauer V., Schaible H.-G., Weiretter F., Freudenberger U. The involvement of substance P and neurokinin-1 receptors in the responses of rat dorsal horn neurons to noxious but not to innocuous mechanical stimuli applied to the knee joint. Brain Res. 666:1994;207-215.
33. Neugebauer V., Geisslinger G., Rümenapp P., Weiretter F., Szelenyi I., Brune K., Schaible H.-G. Antinociceptive effects of R(-)- and S(+)-flurbiprofen on rat spinal dorsal horn neurons rendered hyperexcitable by an acute knee joint inflammation. J. Pharmacol. Exp. Ther. 275:1995;618-628.
34. Neugebauer V., Weiretter F., Schaible H.-G. The involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J. Neurophysiol. 73:1995;1574-1583.
35. Neugebauer V., Rümenapp P., Schaible H.-G. The role of spinal neurokinin-2 receptors in the processing of nociceptive information from the joint and in the generation and maintenance of inflammation-evoked hyperexcitability of dorsal horn neurons in the rat. Eur. J. Neurosci. 8:1996;249-260.
36. Neugebauer V., Rümenapp P., Schaible H.-G. Calcitonin gene-related peptide is involved in the generation and maintenance of hyperexcitability of dorsal horn neurons observed during development of acute inflammation in rat's knee joint. Neuroscience. 71:1996;1095-1109.
37. R. Oelkers, W. Neupert, K. Williams, K. Brune, G. Geisslinger, Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid, Br. J. Clin. Pharmacol. (1997) in press.
38. Peskar B.M., Kluge S., Peskar B.A., Menzel-Soglowek S., Brune K. Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs in vitro. Prostaglandins. 42:1991;515-531.
39. Schaible H.-G., Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain. 55:1993;5-54.
40. Schaible H.-G., Jarrott B., Hope P.J., Duggan A.W. Release of immunoreactive substance P in the cat spinal cord during development of acute arthritis in cat's knee: a study with antibody bearing microprobes. Brain Res. 529:1990;214-223.
41. 2α. Brain Res. 373:1986;81-84.
42. Tortorici V., Vanegas H. Anti-nociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off and on cells. Eur. J. Neurosci. 7:1995;1857-1865.
43. Urban L., Thompson S.W.N., Dray A. Modulation of spinal excitability: cooperation between neurokinin and excitatory amino acid transmitters. TINS. 17:1994;432-438.
44. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 231:1971;232-235.
45. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 14:1994;4687-4997.
46. Zieglgänsberger W., Tulloch I.F. Effects of substance P on neurons in the dorsal horn of the spinal cord of the cat. Brain Res. 166:1979;273-282.